BNTX

92.34

0.28% 0.255

Handel nachbörslich: 92.02 -0.32 -0.35%

Biontech Se Adr (BNTX)

Überblick Nachrichten Preisverlauf Optionskette Warum fällt BNTX? Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

$92.08

Offen:

$92.75

24-Stunden-Volumen:

1.18M

Relative Volume:

1.10

Marktkapitalisierung:

$22.78B

Einnahmen:

$2.97B

Nettoeinkommen (Verlust:

$-812.83M

KGV:

-27.19

EPS:

-3.3962

Netto-Cashflow:

$-1.24B

1W Leistung:

-2.57%

1M Leistung:

-6.73%

6M Leistung:

-7.40%

1J Leistung:

+0.15%

1-Tages-Spanne:

$89.77

$93.73

1-Wochen-Bereich:

$89.77

$97.49

52-Wochen-Spanne:

$76.53

$131.49

Biontech Se Adr Stock (BNTX) Company Profile

Firmenname

Biontech Se Adr

Sektor

Healthcare (1155)

Branche

Biotechnology (673)

Telefon

Adresse

Mitarbeiter

6,772

Twitter

@BioNTech_Group

Nächster Verdiensttermin

2025-03-10

Neueste SEC-Einreichungen

BNTX's Discussions on Twitter

Vergleichen Sie BNTX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BNTX Biontech Se Adr	92.34	22.78B	2.97B	-812.83M	-1.24B	-3.3962
VRTX Vertex Pharmaceuticals Inc	434.38	110.32B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	584.99	59.13B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	561.75	34.75B	2.58B	1.06B	-1.28B	16.33
ALNY Alnylam Pharmaceuticals Inc	283.40	33.69B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	225.77	25.49B	3.81B	-644.79M	-669.77M	-6.24

Biontech Se Adr Stock (BNTX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-03-13	Eingeleitet	Citigroup	Buy
2025-01-10	Eingeleitet	Truist	Buy
2024-12-11	Eingeleitet	Wells Fargo	Overweight
2024-12-02	Bestätigt	BMO Capital Markets	Outperform
2024-11-19	Eingeleitet	Berenberg	Buy
2024-11-19	Hochstufung	Evercore ISI	In-line → Outperform
2024-11-08	Hochstufung	Goldman	Neutral → Buy
2024-09-24	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2024-09-17	Hochstufung	Jefferies	Hold → Buy
2024-09-16	Hochstufung	JP Morgan	Underweight → Neutral
2024-08-07	Hochstufung	Deutsche Bank	Hold → Buy
2024-08-02	Hochstufung	HSBC Securities	Hold → Buy
2024-05-14	Eingeleitet	Evercore ISI	In-line
2024-02-23	Eingeleitet	BMO Capital Markets	Outperform
2024-01-05	Eingeleitet	Oppenheimer	Perform
2023-12-01	Herabstufung	JP Morgan	Neutral → Underweight
2023-10-16	Herabstufung	HSBC Securities	Buy → Hold
2023-07-14	Eingeleitet	HSBC Securities	Buy
2023-05-17	Hochstufung	Redburn	Neutral → Buy
2022-12-15	Hochstufung	BofA Securities	Neutral → Buy
2022-08-17	Eingeleitet	Cowen	Market Perform
2022-07-13	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2022-07-06	Fortgesetzt	Canaccord Genuity	Buy
2022-02-01	Hochstufung	Redburn	Sell → Neutral
2021-12-16	Eingeleitet	Morgan Stanley	Equal-Weight
2021-11-10	Hochstufung	H.C. Wainwright	Neutral → Buy
2021-10-22	Eingeleitet	Deutsche Bank	Hold
2021-10-07	Eingeleitet	Jefferies	Hold
2021-08-11	Hochstufung	Bryan Garnier	Neutral → Buy
2021-07-19	Fortgesetzt	Wolfe Research	Outperform
2021-06-16	Herabstufung	Redburn	Neutral → Sell
2021-05-18	Eingeleitet	Goldman	Neutral
2021-05-11	Herabstufung	Bryan Garnier	Buy → Neutral
2020-12-01	Herabstufung	BofA Securities	Buy → Neutral
2020-08-03	Fortgesetzt	Berenberg	Buy
2020-07-21	Hochstufung	BofA Securities	Neutral → Buy
2020-06-30	Herabstufung	H.C. Wainwright	Buy → Neutral
2020-05-19	Hochstufung	H.C. Wainwright	Neutral → Buy
2020-04-28	Herabstufung	BofA/Merrill	Buy → Neutral
2020-03-18	Herabstufung	JP Morgan	Overweight → Neutral
2020-03-09	Eingeleitet	H.C. Wainwright	Neutral
2020-01-24	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2020-01-22	Herabstufung	UBS	Buy → Neutral
2019-11-05	Eingeleitet	Wolfe Research	Outperform
2019-11-04	Eingeleitet	Berenberg	Buy
2019-11-04	Eingeleitet	BofA/Merrill	Buy
2019-11-04	Eingeleitet	Canaccord Genuity	Buy
2019-11-04	Eingeleitet	JP Morgan	Overweight
2019-11-04	Eingeleitet	SVB Leerink	Outperform
2019-11-04	Eingeleitet	UBS	Buy

Alle ansehen

Biontech Se Adr Aktie (BNTX) Neueste Nachrichten

May 10, 2025

BioNTech SE ADR (NASDAQ: BNTX): Getting A Free Pass? - Stocksregister

May 10, 2025

May 07, 2025

Balance Sheet Breakdown: BioNTech SE ADR (BNTX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

May 07, 2025

May 06, 2025

BioNTech’s Earnings Call: Oncology Progress Amid Financial Challenges - TipRanks

May 05, 2025

May 01, 2025

BioNTech SE ADR [NASDAQ: BNTX] Sees Increase in Stock Value - knoxdaily.com

May 01, 2025

HRL Shares Experience Surge in Value - knoxdaily.com

May 01, 2025

Nordson Corp [NDSN] stock for 268,620 USD was sold by Lovass Stephen - knoxdaily.com

May 01, 2025

Hanesbrands Inc [HBI] Records 200-Day SMA of $6.81 - knoxdaily.com

May 01, 2025

Apr 30, 2025

Ratio Review: Analyzing Regency Centers Corporation (REG)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

Apr 30, 2025

Financial Metrics Exploration: Understanding MARA Holdings Inc (MARA) Through Ratios - DWinneX

Apr 30, 2025

Financial Fitness Check: Examining BioNTech SE ADR (BNTX)’s Key Ratios - DWinneX

Apr 30, 2025

The growth track for BioNTech SE ADR (BNTX) has changed recently - Sete News

Apr 30, 2025

Financial Health Report: Arthur J. Gallagher & Co (AJG)’s Ratios Tell a Tale - DWinneX

Apr 30, 2025

Financial Fitness Check: Examining B. Riley Financial Inc (RILY)’s Key Ratios - DWinneX

Apr 30, 2025

Apr 29, 2025

Pfizer Q1 Earnings Beat Estimates, Several Headwinds Hurt Sales - sharewise

Apr 29, 2025

A year in review: BioNTech SE ADR (BNTX)’s performance in the last year - uspostnews.com

Apr 29, 2025

Apr 28, 2025

BioNTech SE ADR (NASDAQ: BNTX) Could Make Significant Gains? - Marketing Sentinel

Apr 28, 2025

Investors Could Make -86.23% On NOV Inc (NYSE: NOV) Stock - Marketing Sentinel

Apr 28, 2025

Let’s Start With The Stock Forecast For UroGen Pharma Ltd (NASDAQ: URGN) - Marketing Sentinel

Apr 28, 2025

Is Murphy Oil Corp (NYSE: MUR) Stock Set To Rise More? - Marketing Sentinel

Apr 28, 2025

Why Is Summit Therapeutics Stock Trading Higher On Monday? - Benzinga

Apr 28, 2025